Lexaria Bioscience Corp.
LEXX | NASDAQ
$3.33
-$0.09 (-2.63%)
Sep 22, 2026, 1:34 PM ET · Market open
TTM Period Ending | Q3 2026 May 30, 2026 | Q2 2026 Feb 27, 2026 | Q1 2026 Nov 29, 2025 | Q4 2025 Aug 30, 2025 | Q3 2025 May 30, 2025 | Q2 2025 Feb 27, 2025 | Q1 2025 Nov 29, 2024 | Q4 2024 Aug 30, 2024 | Q3 2024 May 30, 2024 | Q2 2024 Feb 28, 2024 | Q1 2024 Nov 29, 2023 | Q4 2023 Aug 30, 2023 | Q3 2023 May 30, 2023 | Q2 2023 Feb 27, 2023 | Q1 2023 Nov 29, 2022 | Q4 2022 Aug 30, 2022 | Q3 2022 May 30, 2022 | Q2 2022 Feb 27, 2022 | Q1 2022 Nov 29, 2021 | Q4 2021 Aug 30, 2021 | Q3 2021 May 30, 2021 | Q2 2021 Feb 27, 2021 | Q1 2021 Nov 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 194K | 368K | 522K | 705.92K | 615.92K | 525.92K | 496.92K | 464.28K | 376.85K | 370.55K | 245.58K | 192.03K | 306.62K | 328.63K | 339.25K | 255.4K | 175.27K | 279.61K | 440.96K | 722.74K | 825.46K | 657.82K | 503.37K |
Cost of Revenue | n/a | n/a | n/a | 2.72K | 2.72K | 2.72K | 2.72K | 4.82K | 4.82K | 17.57K | 20.53K | 31.5K | 72.75K | 78.64K | 82.07K | 71.84K | 50.9K | 92.26K | 116.44K | 175.35K | 168.14K | 128.47K | 156K |
Gross Profit | 194K | 368K | 522K | 703.2K | 613.2K | 523.2K | 494.2K | 459.46K | 372.02K | 352.98K | 225.05K | 160.53K | 233.87K | 249.99K | 257.19K | 183.56K | 124.37K | 187.35K | 324.52K | 547.39K | 657.32K | 529.36K | 347.36K |
Operating Income | -7.71M | -9.46M | -10.76M | -11.88M | -11.4M | -9.39M | -7.3M | -5.75M | -4.62M | -5.28M | -5.93M | -6.49M | -6.93M | -6.95M | -7.08M | -7.38M | -7.3M | -7.45M | -7.1M | -5.81M | -5.16M | -3.97M | -3.93M |
Interest Income | 5.43K | 4.79K | 3.02K | 3.02K | 7.19K | 7K | 7K | 14.31K | 16.34K | 31.78K | 46.77K | 43.19K | 34.17K | 18.73K | 3.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -7.74M | -9.53M | -10.8M | -11.91M | -11.4M | -9.39M | -7.33M | -5.81M | -4.87M | -5.47M | -6.13M | -6.71M | -6.98M | -7.01M | -7.15M | -7.38M | -7.17M | -7.32M | -5.45M | -4.16M | -3.63M | -2.48M | -3.96M |
Net Income | -7.73M | -9.53M | -10.79M | -11.9M | -11.39M | -9.38M | -7.32M | -5.8M | -4.85M | -5.44M | -6.09M | -6.66M | -6.89M | -6.9M | -7.03M | -7.27M | -6.98M | -7.15M | -5.32M | -4.03M | -3.56M | -2.37M | -3.72M |
Selling & General & Admin | 3.9M | 4.09M | 4.33M | 4.35M | 4.68M | 4.73M | 4.06M | 3.85M | 3.1M | 2.67M | 2.75M | 2.98M | 3.64M | 4.57M | 5.12M | 5.72M | 5.58M | 6.09M | 5.98M | 5.18M | 4.89M | 3.98M | 3.72M |
Research & Development | 4M | 5.75M | 6.96M | 8.24M | 7.32M | 5.18M | 3.74M | 2.36M | 1.89M | 2.96M | 3.41M | 3.67M | 3.52M | 2.63M | 2.21M | 1.84M | 1.93M | 1.63M | 1.53M | 1.26M | 891.6K | 461.71K | 471.87K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83.79K | -83.79K | -83.79K | -83.79K | 28.88K | 56.96K | 85.24K |
Operating Expenses | 7.9M | 9.83M | 11.29M | 12.58M | 12.01M | 9.91M | 7.8M | 6.21M | 4.99M | 5.63M | 6.16M | 6.65M | 7.17M | 7.2M | 7.33M | 7.57M | 7.42M | 7.64M | 7.43M | 6.36M | 5.81M | 4.5M | 4.27M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -410.27K | -410.27K | -410.27K | -410.27K | 74.78K | 122.9K | 156.81K |
Cost & Expenses | 7.9M | 9.83M | 11.29M | 12.59M | 12.01M | 9.91M | 7.8M | 6.22M | 5M | 5.65M | 6.18M | 6.68M | 7.24M | 7.28M | 7.41M | 7.64M | 7.47M | 7.73M | 7.54M | 6.54M | 5.98M | 4.63M | 4.43M |
Income Tax Expense | 4.4K | 4.39K | 1.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.65M | 1.63M | 1.43M | 1.3M | 1.22M | 1.17M | 1.11M | 874.64K | 923.68K | 717.68K | 603.44K | 440.94K | 429.4K | 396.73K | 396.73K | 392.35K | 396.73K | 394.08K | 381.78K | 340.29K | 340.29K | 270.19K | 200.1K |
Shares Outstanding (Diluted) | 1.65M | 1.63M | 1.43M | 1.3M | 1.22M | 1.17M | 1.11M | 874.64K | 923.68K | 717.68K | 603.44K | 440.94K | 429.4K | 396.73K | 396.73K | 392.35K | 396.73K | 394.08K | 381.78K | 340.29K | 340.29K | 270.19K | 200.1K |
EPS (Basic) | -5.32 | -7.27 | -8.62 | -9.90 | -10.35 | -9.15 | -7.80 | -7.35 | -6.60 | -10.20 | -12.60 | -15.15 | -17.10 | -17.55 | -17.85 | -18.60 | -18.30 | -19.80 | -14.85 | -13.05 | -13.35 | -13.20 | -19.95 |
EPS (Diluted) | -5.32 | -7.27 | -8.62 | -9.90 | -10.35 | -9.15 | -7.80 | -7.35 | -6.60 | -10.20 | -12.60 | -15.15 | -17.10 | -17.55 | -17.85 | -18.60 | -18.30 | -19.80 | -14.85 | -13.05 | -13.50 | -13.35 | -20.10 |
EBITDA | -7.68M | -9.45M | -10.73M | -11.82M | -11.34M | -9.35M | -7.27M | -5.76M | -4.74M | -5.33M | -5.98M | -6.57M | -6.84M | -6.87M | -7.01M | -7.24M | -7.03M | -7.18M | -6.83M | -5.54M | -5.04M | -3.86M | -3.81M |
EBIT | -7.74M | -9.53M | -10.8M | -11.91M | -11.4M | -9.39M | -7.33M | -5.81M | -4.87M | -5.47M | -6.13M | -6.71M | -6.98M | -7.01M | -7.15M | -7.38M | -7.17M | -7.32M | -6.98M | -5.69M | -5.16M | -3.97M | -3.93M |
Depreciation & Amortization | 57.37K | 88.32K | 71.5K | 87.83K | 58.67K | 42.79K | 56.44K | 52.02K | 130.71K | 140.65K | 149.45K | 145.4K | 137.8K | 136.68K | 138.12K | 141.32K | 141.8K | 145.83K | 147.6K | 147.6K | 112.66K | 112.82K | 113.17K |
Add to Watchlist
Select watchlists to add or remove LEXX